文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

实验性肺炎球菌定植揭示病毒抑制的HIV成人易感性的体液免疫相关因素

Experimental pneumococcal carriage reveals humoral correlates of susceptibility in virally suppressed adults with HIV.
PubMed 文献 · J Infect Dis · 2026-10-15

在撒哈拉以南非洲,尽管抗逆转录病毒治疗有效,HIV感染者(PWH)仍面临肺炎球菌定植和疾病高风险。本研究对病毒学抑制且临床稳定的PWH(n=60)和未感染HIV成人(n=60)进行鼻内活肺炎球菌6B型攻击,通过培养和血清分型确定实验性定植,并用ELISA检测鼻洗液和血清中荚膜及全菌IgG,用流式细胞术检测抗体结合。结果显示两组基线肺炎球菌IgG水平相似,攻击后均未升高IgG浓度;PWH的定植易感性与较低的基线血清荚膜6B IgG(0.84 vs 2.33 µg/mL,p<0.01)、较低的鼻荚膜6B IgG(328 vs 761 pg/mL,p=0.07)和较低的鼻全菌IgG(92.2 vs 205 AU/mL,p=0.02)相关,这些关联在未感染HIV者中未观察到;未感染HIV者定植与第21天IgG结合较基线增加相关(120 vs 209 AU,Friedman χ2=11.1,p=0.004),而PWH中未检测到(79.2 vs 72.3 AU,χ2=0.67,p=0.72)。结论认为两组基线肺炎球菌IgG水平和功能相似,但实验性攻击揭示了PWH与未感染HIV成人之间肺炎球菌定植的体液免疫相关因素存在特定差异,支持评估增强PWH肺炎球菌抗体浓度和功能的疫苗接种策略。

要点

  • PWH与未感染HIV成人基线肺炎球菌IgG水平和抗体结合相似。
  • PWH定植易感与较低基线血清荚膜6B IgG(0.84 vs 2.33 µg/mL,p<0.01)相关。
  • 未感染HIV者定植伴第21天IgG结合较基线增加,PWH中未检测到。

核心结论

  • 实验性攻击揭示PWH与未感染HIV成人肺炎球菌定植的体液免疫相关因素存在特定差异。
  • 支持评估增强PWH肺炎球菌抗体浓度和功能的疫苗接种策略。

研究设计与样本

  • 病毒学抑制、临床稳定的PWH(n=60)和未感染HIV成人(n=60)接受鼻内活肺炎球菌6B型攻击。
  • 通过鼻洗液培养和血清分型确定实验性定植,ELISA检测鼻洗液和血清荚膜及全菌IgG,流式细胞术检测抗体结合。

主要发现

  • 两组基线肺炎球菌荚膜IgG、全菌IgG和抗体结合相似,攻击后两组IgG浓度均未升高。
  • PWH定植易感与较低基线血清荚膜6B IgG(0.84 vs 2.33 µg/mL,p<0.01)、较低鼻荚膜6B IgG(328 vs 761 pg/mL,p=0.07)和较低鼻全菌IgG(92.2 vs 205 AU/mL,p=0.02)相关,未感染HIV者中未观察到此关联。
  • 未感染HIV者定植与第21天IgG结合较基线增加相关(120 vs 209 AU,Friedman χ2=11.1,p=0.004),PWH中未检测到(79.2 vs 72.3 AU,χ2=0.67,p=0.72)。

关键数值与推荐

  • PWH定植易感相关:血清荚膜6B IgG 0.84 vs 2.33 µg/mL(p<0.01)。
  • PWH定植易感相关:鼻荚膜6B IgG 328 vs 761 pg/mL(p=0.07)。
  • PWH定植易感相关:鼻全菌IgG 92.2 vs 205 AU/mL(p=0.02)。
  • 未感染HIV者定植相关IgG结合增加:120 vs 209 AU(Friedman χ2=11.1,p=0.004)。
  • PWH中IgG结合变化:79.2 vs 72.3 AU(χ2=0.67,p=0.72)。

临床怎么用

  • 对病毒学抑制的PWH应关注肺炎球菌抗体浓度和功能,而不仅是一般免疫状态。
  • 可考虑评估增强PWH肺炎球菌抗体浓度和功能的疫苗接种策略。
  • 鼻黏膜和血清肺炎球菌IgG水平可能有助于识别PWH中的定植易感者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: People with HIV (PWH) in sub-Saharan Africa remain at high risk of pneumococcal carriage and disease, despite effective antiretroviral therapy. Understanding the immune factors driving this is key to addressing the issue. METHODS: Virally suppressed, clinically stable PWH (n = 60) and HIV-uninfected adults (n = 60) underwent intranasal challenge with live pneumococcus serotype 6B. Experimental carriage was determined by culture and serotyping of nasal wash samples. Pneumococcal capsular and whole-cell IgG in nasal wash and serum samples were measured by ELISA. Antibody binding was measured using a flow cytometry assay. RESULTS: Baseline pneumococcal capsular IgG, whole-cell IgG, and antibody binding were similar between PWH and HIV-uninfected participants. Challenge did not increase IgG concentration in either group. Carriage susceptibility among PWH was associated with lower baseline serum capsular 6B IgG (0.84 vs 2.33 µg/mL, p < 0.01), lower nasal capsular 6B IgG (328 vs 761 pg/mL, p = 0.07), and lower nasal whole-cell IgG (92.2 vs 205 AU/mL, p = 0.02). These associations were not observed in HIV-uninfected participants. Carriage in HIV-uninfected participants was associated with an increase in IgG binding from baseline to day 21 (120 vs 209 AU, Friedman χ2 = 11.1, p = 0.004), which was not detected in PWH (79.2 vs 72.3 AU, χ2 = 0.67, p = 0.72)). CONCLUSION: Baseline pneumococcal IgG levels and function were similar in PWH and HIV-uninfected participants. However, experimental challenge revealed specific differences in humoral correlates of pneumococcal carriage between PWH and HIV-uninfected adults. These findings support evaluation of vaccination strategies to enhance pneumococcal antibody concentration and function in PWH in sub-Saharan Africa.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Doherty K, Hamilton J, Nthandira T, et al. Experimental pneumococcal carriage reveals humoral correlates of susceptibility in virally suppressed adults with HIV. J Infect Dis. 2026. PMID: 42879199. doi:10.1093/infdis/jiag517

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。